Inventor · disambiguated record
Hiroki Torikai
Also filed as: TORIKAI HIROKI
4 granted patents·8 pending applications·146 citations·filing 2012–2023
77Inventor score
Top patents by PatentIndex Score
12 records- 0193US9629877B2Human application of engineered chimeric antigen receptor (CAR) T-cellsUNIV TEXAS·Filed 2014·Granted Apr 25, 2017·131 cites·31 claims
- 0287US11344577B2Car+ T cells genetically modified to eliminate expression of T-cell receptor and/or HLAUNIV TEXAS·Filed 2019·Granted May 31, 2022·3 cites·20 claims
- 0387US10391126B2CAR+ T cells genetically modified to eliminate expression of T-cell receptor and/or HLAUNIV TEXAS·Filed 2012·Granted Aug 27, 2019·12 cites·14 claims
- 0480US2024156929A1Human application of engineered chimeric antigen receptor (car) t-cellsUNIV TEXAS·Filed 2023·Application pending·0 cites
- 0572US11786582B2Human application of engineered chimeric antigen receptor (CAR) T-cellsUNIV TEXAS·Filed 2021·Granted Oct 17, 2023·0 cites·20 claims
- 0668US2022202858A1Methods and compositions for modification of hlaSANGAMO THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 0761US2020085929A1Human application of engineered chimeric antigen receptor (car) t-cellsUNIV TEXAS·Filed 2019·Application pending·0 cites
- 0856US2015037304A1Methods and compositions for modification of hlaSANGAMO BIOSCIENCES INC·Filed 2014·Application pending·0 cites
- 0954US2017224798A1Human application of engineered chimeric antigen receptor (car) t-cellsUNIV TEXAS·Filed 2017·Application pending·0 cites
- 1051US2017216358A1Methods and compositions for modification of hlaSANGAMO THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 1151US2023079539A1Methods for rapid cloning and expression of hla class i cellsUNIV TEXAS·Filed 2021·Application pending·0 cites
- 1236US2017044500A1Application of induced pluripotent stem cells to generate adoptive cell therapy productsUNIV TEXAS·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Hiroki Torikai files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →